Corvus Pharmaceuticals, Inc. (Corvus)

Oncology Corporate Profile

HQ Location

863 Mitten Road, Suite 102
Burlingame, CA 94010

Company Description

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and antibody agents that target the immune system to treat patients with cancer. These agents block or modify crucial immune checkpoints and reprogram immune T cells.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
CPI-444 (+ atezolizumab)monoclonal antibodyVarious cancer typesIGenentech / Roche

View additional information on product candidates here »


Recent News Headlines

There are no news items to display